ulcerative colitis

GPTKB entity

Statements (72)
Predicate Object
gptkbp:instance_of gptkb:disease
gptkbp:affects colon
gptkbp:associated_with environmental factors
genetic factors
immune system dysfunction
gptkbp:can_cause fatigue
joint pain
skin rashes
eye inflammation
gptkbp:can_lead_to gptkb:anemia
malnutrition
dehydration
gptkbp:complication colon cancer
toxic megacolon
gptkbp:diagnosis physical examination
biopsy
medical history
colonoscopy
gptkbp:first_described_by in the 19th century
gptkbp:has_research_areas clinical trials
genetic studies
dietary studies
https://www.w3.org/2000/01/rdf-schema#label ulcerative colitis
gptkbp:is_a_chronic_condition gptkb:true
gptkbp:is_characterized_by inflammation of the colon
ulcer formation
gptkbp:is_common_in gptkb:women
gptkb:Europe
gptkb:Asia
gptkb:North_America
young adults
gptkbp:is_managed_by gptkb:surgery
medications
lifestyle changes
gptkbp:is_often_seen_in gptkb:Crohn's_disease
gptkbp:is_targeted_at stress
infections
certain foods
gptkbp:lifespan increased risk of colorectal cancer
gptkbp:management stress management
dietary changes
gptkbp:premiered_on any age
gptkbp:prevalence 1 in 200 people
gptkbp:requires hospitalization
surgery for severe cases
gptkbp:research ongoing studies
gptkbp:scientific_classification moderate
mild
severe
gptkbp:symptoms weight loss
abdominal pain
diarrhea
rectal bleeding
gptkbp:treatment gptkb:surgery
topical medications
biologics
gastroenterologists
anti-inflammatory drugs
immunosuppressants
oral medications
intravenous medications
gptkbp:type_of chronic inflammatory disease
gptkbp:bfsParent gptkb:Celiac_Disease
gptkb:cyclosporine
gptkb:Humira
gptkb:Stelara
gptkb:Rituximab
gptkb:Remicade
gptkb:Glenn_Frey
gptkb:Immunex_Corporation
gptkb:rituximab
gptkbp:bfsLayer 5